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In the cumutative dose 60g of IVIG the number 
of ptatetets increased to 30G/L and the breeding 
disappeared. We decided to finish the treatment 
increasing number of ptatetets to 50 G/L. 
Conclusion: The use of intravenous immunogtob- 
utins in immunosuppressive doses is indicated in 
patients with thrombocytopenia associated with 
ptatetet associated autoantibodies and resistant 
to conventionat reatment. Severat mechanisms of 
action have been suggested for the therapeutic 
action of IVIG. 
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Background: Currentty, the cotocation of a centrat 
venous catheter (CVC), is an essentiat procedure 
in the medicat care and it impties a significant 
risk of morbidity and mortatity for art the patients. 
Primary nosocomiat bacteremia (PNB) is the princi- 
pat infectious comptication, it increase the days of 
hospitatization, costs and put in risk the rife of the 
patient. 
Objective: To determine the frequency of Noso- 
comiat Bacteremia retated to the use of CVC in 
patients of the Intensive Care Unit, Surgery and 
Medicine wards. 
Methods: From March to September 2005 a descrip- 
tive and prospective study was made in patients 
who carried CVC, hospitatized in ICU and wards of 
surgery and medicine in the "Rufz y P&ez" Univer- 
sity Hospitat of Botivar City, Venezueta. 37 patients 
were studied using the Macki's technique for the 
microbiotogicat diagnosis. 
Results: The frequency of PNB retated to CVC 
was 35.13% (13/37) (X2=3.97, P>0.05). It was 
more frequent in ICU patients 61.53% (8/13) 
(X 2 = 25.77, P < 0.001 ), in medicine services 35.45% 
(5/13), there was not any case reported in surgery 
wards. The Gram-positive cocci were the princi- 
pat etiotogica[ agents 62.41% (10/16). The iden- 
tified microorganisms were Staphylococcus au- 
reus in 3/16, Staphylococcus haemolyticus 3/16, 
Pseudomonas aerusinosa 3/16, Staphylococcus epi- 
dermidis 2/16, and Staphylococcus warneri 2/16 
(X2=4.00; P>0.05). The identified factors of risk 
were: duration of CVC greater than 4 days, pres- 
ence of previous infection to the entrance site of 
catheter, difficutt insertion of the CVC, previous 
invasive procedures and severity of undertying dis- 
ease or associate. The protonged maintenance of 
the CVC was the more important factor 27.02% 
(10/37) (X 2 =4.25, P >0.05). The more frequentty 
observed comptications were: protonged hospitat- 
ization in 53.87% (7/13), increase of costs 53.87% 
(7/13) and increase of morbidity 23.07% (3/13) 
(X 2 = 8.18; P < 0.05). There was no mortatity in pa- 
tients with PNB retated to CVC. 
Conclusions: It was demonstrated that in ICU the 
frequency of PNB retated to CVC was greater than 
in the surgicat and medicat wards. The Macki's 
technique was used in this study, by being simpte 
in its apptication, tess expensive and retiabte. 
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Background: Experimentat evidence suggests that 
time of beta-tactam antibiotics brood revers above 
MIC is a key factor for treatment efficacy. Low 
revers may be associated with treatment faiture, 
white high revers may increase toxicity, especiatty 
in patients with impaired renat function. 
Objective: To report the experience with TDM in 
adutt patients receiving IMP or CEF therapy. 
Methods: Retrospective anatysis of consecutive IMP 
or CEF TDM during a 1-year period. Initiat drug dos- 
ing was based on standard recommendations. IMP 
or CEF trough brood revers (Cm~n) were measured 
by HPLC. Interpretation of Cm~n as appropriate (A), 
inappropriate tow (L) or inappropriate high (H) 
was based on MIC (when avaitabte), ctinicat and 
microbiotogicat response, renat function, and drug 
brood revers reported in ctinicat studies. For L or H 
drug revers, interventions were proposed. 
Results: 56 drug revers were measured (IMP, n = 30; 
CEF, n=26) in 29 hemato-oncotogy, 11 intensive 
care, and 16 other adutt patients. Treatment indi- 
cations were microbiotogicatty (27) or ctinicatty (7) 
documented infections or unexptained fever (21). 
Dairy dosing ranged from 500 to 4000 mg (IMP) and 
500 to 6000 mg (CEF). TDM was performed 4 days 
(median, range 1-25) after treatment initiation: 
Cm~n ranged from 0 to 13 (IMP) and 0.7 to 61 mg/L 
